Form 4: Hims & Hers Health Chief Commercial Officer Executes Stock Transactions

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including acquisitions, disposals, and tax withholdings.

Summary

• Michael Chi, the Chief Commercial Officer of Hims & Hers Health, engaged in several transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• On December 13, 2024, Mr. Chi acquired 76,508 shares of Class A Common Stock through the vesting of RSUs.
• Also on December 13, 2024, 42,304 shares were withheld by the company to cover tax obligations related to the vesting of RSUs at a price of $30.02 per share.
• On December 17, 2024, Mr. Chi sold 25,550 shares of Class A Common Stock at a price of $32.20 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
• The vesting of RSUs is subject to a four-year service-based vesting schedule, with varying start dates and quarterly vesting periods.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions, which are neither particularly positive nor negative. The pre-arranged trading plan mitigates concerns about insider trading, but the sale of shares could be viewed with slight caution.

Positives

• The vesting of RSUs indicates that performance milestones have been met.
• The execution of a pre-arranged trading plan provides transparency and reduces the risk of insider trading concerns.

Negatives

• The sale of 25,550 shares could be interpreted as a lack of confidence in the company's future performance, although it is part of a pre-arranged plan.
• The withholding of shares for tax obligations reduces the net gain from the RSU vesting.

Risks

• The market may react negatively to the sale of shares by a key executive, even if it is part of a pre-arranged plan.
• Fluctuations in the stock price could impact the value of the remaining shares and RSUs held by Mr. Chi.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of key executives.

Comparison to Industry Standards

• Similar filings are common across all publicly traded companies, especially those with equity-based compensation plans.
• The use of a Rule 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
• The vesting schedules for RSUs are typical for executive compensation packages.

Stakeholder Impact

• Shareholders may be interested in the trading activity of key executives.
• The transactions have a minor impact on the overall share float.

Key Dates

Keywords

Hims & Hers Health, HIMS, Michael Chi, Chief Commercial Officer, Class A Common Stock, Restricted Stock Units, RSU, Rule 10b5-1, insider trading, stock transaction